MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens

Circulation Research

Volumn 120, Issue 2, 2017, Pages 418-435

  Sunderland, Nicholas ^a   Skroblin, Philipp ^a   Barwari, Temo ^a   Huntley, Rachael P ^b   Lu, Ruifang ^a   Joshi, Abhishek ^a   Lovering, Ruth C ^b   Mayr, Manuel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

acute coronary syndrome; biomarker; noncoding RNA; platelet; platelet inhibitor

Indexed keywords

ADAM PROTEIN; BIOLOGICAL MARKER; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 126; MICRORNA 223; PHOSPHATIDYLCHOLINE; PURINERGIC P2Y12 RECEPTOR; RIBONUCLEASE INHIBITOR; RIBOSOME RNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA;

CIRCULATION; DISEASE ASSOCIATION; EXOSOME; EXTRACELLULAR SPACE; GENE ONTOLOGY; HEMOLYSIS; HUMAN; MEASUREMENT; NONHUMAN; PLASMA; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA DEGRADATION; SERUM; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; ANIMAL; BLOOD; BLOOD CLOTTING; GENETICS; METABOLISM; PHYSIOLOGY; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; HUMANS; MICRORNAS; PLATELET ACTIVATION; RNA, UNTRANSLATED; THROMBOSIS;

EID: 85009854458     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309303     Document Type: Review

References (110)

1. Gurbel PA, Jeong YH, Navarese EP, Tantry US. Platelet-mediated thrombosis: from bench to bedside. Circ Res. 2016;118:1380-1391. doi: 10.1161/CIRCRESAHA.115.307016.
2. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem. 1987;164:189-195.
3. Warshaw AL, Laster L, Shulman NR. Protein synthesis by human platelets. J Biol Chem. 1967;242:2094-2097.
4. Bray PF, McKenzie SE, Edelstein LC, Nagalla S, Delgrosso K, Ertel A, Kupper J, Jing Y, Londin E, Loher P, Chen HW, Fortina P, Rigoutsos I. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics. 2013;14:1. doi: 10.1186/1471-2164-14-1.
5. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118:e101-e111. doi: 10.1182/blood-2011-03-339705.
6. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol. 2009;16:961-966. doi: 10.1038/nsmb.1651.
7. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood. 2011;117:5189-5197. doi: 10.1182/blood-2010-09-299719.
8. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-10518. doi: 10.1073/pnas.0804549105.
9. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-5008. doi: 10.1073/pnas.1019055108.
10. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423-433. doi: 10.1038/ncb2210.
11. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223-7233. doi: 10.1093/nar/gkr254.
12. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3:e3694. doi: 10.1371/journal.pone.0003694.
13. Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, Battinelli E, Klement GL, Sola-Visner M, Italiano JE Jr. Megakaryocytederived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood. 2009;113:1112-1121. doi: 10.1182/blood-2008-06-163832.
14. Burnouf T, Goubran HA, Chou ML, Devos D, Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev. 2014;28:155-166. doi: 10.1016/j.blre.2014.04.002.
15. Italiano JE Jr, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol. 2010;17:578-584. doi: 10.1097/MOH.0b013e32833e77e.e.
16. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659. doi: 10.1038/ncb1596.
17. Laffont B, Corduan A, Plé H, Duchez AC, Cloutier N, Boilard E, Provost P. Activated platelets can deliver mRNA regulatory Ago2microRNA complexes to endothelial cells via microparticles. Blood. 2013;122:253-261. doi: 10.1182/blood-2013-03-492801.
18. McManus DD, Freedman JE. MicroRNAs in platelet function and cardiovascular disease. Nat Rev Cardiol. 2015;12:711-717. doi: 10.1038/nrcardio.2015.101.
19. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68-D73. doi: 10.1093/nar/gkt1181.
20. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233. doi: 10.1016/j.cell.2009.01.002.
21. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92-105. doi: 10.1101/gr.082701.108.
22. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455:58-63. doi: 10.1038/nature07228.
23. Barwari T, Joshi A, Mayr M. MicroRNAs in cardiovascular disease. J Am Coll Cardiol. 2016;68:2577-2584. doi: 10.1016/j.jacc.2016.09.945.
24. Ipsaro JJ, Joshua-Tor L. From guide to target: molecular insights into eukaryotic RNA-interference machinery. Nat Struct Mol Biol. 2015;22:20-28. doi: 10.1038/nsmb.2931.
25. Jonas S, Izaurralde E. Towards a molecular understanding of microRNAmediated gene silencing. Nat Rev Genet. 2015;16:421-433. doi: 10.1038/nrg3965.
26. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004;432:231-235. doi: 10.1038/nature03049.
27. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432:235-240. doi: 10.1038/nature03120.
28. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740-744. doi: 10.1038/nature03868.
29. Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 2007;8:23-36. doi: 10.1038/nrm2085.
30. Opalinska JB, Bersenev A, Zhang Z, Schmaier AA, Choi J, Yao Y, D'Souza J, Tong W, Weiss MJ. MicroRNA expression in maturing murine megakaryocytes. Blood. 2010;116:e128-e138. doi: 10.1182/blood-2010-06-292920.
31. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110:483-495. doi: 10.1161/CIRCRESAHA.111.247452.
32. Kaudewitz D, Skroblin P, Bender LH, et al. Association of microRNAs and YRNAs with platelet function. Circ Res. 2016;118:420-432. doi: 10.1161/CIRCRESAHA.114.305663.
33. Mayr M, Zampetaki A, Willeit P, Willeit J, Kiechl S. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler Thromb Vasc Biol. 2013;33:206-214. doi: 10.1161/ATVBAHA.112.300141.
34. Willeit P, Zampetaki A, Dudek K, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res. 2013;112:595-600. doi: 10.1161/CIRCRESAHA.111.300539.
35. Bleazard T, Lamb JA, Griffiths-Jones S. Bias in microRNA functional enrichment analysis. Bioinformatics. 2015;31:1592-1598. doi: 10.1093/bioinformatics/btv023.
36. Huntley RP, Sitnikov D, Orlic-Milacic M, et al. Guidelines for the functional annotation of microRNAs using the gene ontology. RNA. 2016;22:667-676. doi: 10.1261/rna.055301.115.
37. Gene Ontology microRNAs. Available at https://www.ucl.ac.uk/functional-gene-annotation/cardiovascular/projects/tabs/gene-ontology-mirnas. Accessed November 23, 2016.
38. AmiGO2; Kaudewitz et al. Available at http://amigo.geneontology.org/amigo/reference/PMID:26646931. Accessed November 23, 2016.
39. Wolin SL, Steitz JA. Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single-copy in the human genome. Cell. 1983;32:735-744.
40. Perreault J, Perreault JP, Boire G. Ro-associated Y RNAs in metazoans: evolution and diversification. Mol Biol Evol. 2007;24:1678-1689. doi: 10.1093/molbev/msm084.
41. Christov CP, Gardiner TJ, Szüts D, Krude T. Functional requirement of noncoding Y RNAs for human chromosomal DNA replication. Mol Cell Biol. 2006;26:6993-7004. doi: 10.1128/MCB.01060-06.
42. Hogg JR, Collins K. Human Y5 RNA specializes a Ro ribonucleoprotein for 5S ribosomal RNA quality control. Genes Dev. 2007;21:3067-3072. doi: 10.1101/gad.1603907.
43. Chen X, Wolin SL. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J Mol Med (Berl). 2004;82:232-239.
44. Dhahbi JM, Spindler SR, Atamna H, Boffelli D, Mote P, Martin Di. 5'-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma. Physiol Genomics. 2013;45:990-998. doi: 10.1152/physiolgenomics.00129.2013.
45. Nicolas FE, Hall AE, Csorba T, Turnbull C, Dalmay T. Biogenesis of Y RNA-derived small RNAs is independent of the microRNA pathway. FEBS Lett. 2012;586:1226-1230. doi: 10.1016/j.febslet.2012.03.026.
46. Böttcher K, Wenzel A, Warnecke JM. Investigation of the origin of extracellular RNA in human cell culture. Ann N Y Acad Sci. 2006;1075:50-56. doi: 10.1196/annals.1368.006.
47. Cabrera-Fuentes HA, Ruiz-Meana M, Simsekyilmaz S, et al. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-in cardiac ischaemia/reperfusion injury. Thromb Haemost. 2014;112:1110-1119. doi: 10.1160/TH14-08-0703.
48. Zernecke A, Preissner KT. Extracellular ribonucleic acids (RNA) enter the stage in cardiovascular disease. Circ Res. 2016;118:469-479. doi: 10.1161/CIRCRESAHA.115.307961.
49. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775-1789. doi: 10.1101/gr.132159.111.
50. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res. 2014;114:1569-1575. doi: 10.1161/CIRCRESAHA.114.303915.
51. Skroblin P, Mayr M. Going long: long non-coding RNAs as biomarkers. Circ Res. 2014;115:607-609. doi: 10.1161/CIRCRESAHA.114.304839.
52. Alhasan AA, Izuogu OG, Al-Balool HH, Steyn JS, Evans A, Colzani M, Ghevaert C, Mountford JC, Marenah L, Elliott DJ, Santibanez-Koref M, Jackson MS. Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood. 2016;127:e1-e11. doi: 10.1182/blood-2015-06-649434.
53. Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73:3852-3856.
54. Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7:e30733. doi: 10.1371/journal. pone.0030733.
55. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333-338. doi: 10.1038/nature11928.
56. Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17:205-211. doi: 10.1038/nrm.2015.32.
57. Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA, Goodall GJ. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125-1134. doi: 10.1016/j.cell.2015.02.014.
58. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384-388. doi: 10.1038/nature11993.
59. Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS ONE. 2012;7:e50746. doi: 10.1371/journal.pone.0050746.
60. Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, McKenzie SE, Dong JF, Shaw CA, Bray PF. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood. 2014;123:e37-e45. doi: 10.1182/blood-2013-12-544692.
61. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7:e41561. doi: 10.1371/journal.pone.0041561.
62. Yu S, Deng G, Qian D, Xie Z, Sun H, Huang D, Li Q. Detection of apoptosis-associated microRNA in human apheresis platelets during storage by quantitative real-time polymerase chain reaction analysis. Blood Transfus. 2014;12:541-547. doi: 10.2450/2014.0291-13.
63. Ferreiro JL, Sibbing D, Angiolillo DJ. Platelet function testing and risk of bleeding complications. Thromb Haemost. 2010;103:1128-1135. doi: 10.1160/TH09-11-0799.
64. Capodanno D, Patel A, Dharmashankar K, Ferreiro JL, Ueno M, Kodali M, Tomasello SD, Capranzano P, Seecheran N, Darlington A, Tello-Montoliu A, Desai B, Bass TA, Angiolillo DJ. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. Circ Cardiovasc Interv. 2011;4:180-187. doi: 10.1161/CIRCINTERVENTIONS.110.960187.
65. Bernlochner I, Goedel A, Plischke C, Schüpke S, Haller B, Schulz C, Mayer K, Morath T, Braun S, Schunkert H, Siess W, Kastrati A, Laugwitz KL. Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome. Eur Heart J. 2015;36:3202-3210. doi: 10.1093/eurheartj/ehv326.
66. Stratz C, Nührenberg TG, Binder H, Valina CM, Trenk D, Hochholzer W, Neumann FJ, Fiebich BL. Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb Haemost. 2012;107:634-641. doi: 10.1160/TH11-10-0742.
67. Gidlöf O, van der Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C, Erlinge D. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood. 2013;121:3908-3917, S1. doi: 10.1182/blood-2012-10-461798.
68. Ward JA, Esa N, Pidikiti R, Freedman JE, Keaney JF, Tanriverdi K, Vitseva O, Ambros V, Lee R, McManus DD. Circulating cell and plasma microRNA profiles differ between Non-ST-segment and ST-segmentelevation myocardial infarction. Fam Med Med Sci Res. 2013;2:108. doi: 10.4172/2327-4972.1000108.
69. Elgheznawy A, Shi L, Hu J, Wittig I, Laban H, Pircher J, Mann A, Provost P, Randriamboavonjy V, Fleming I. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. Circ Res. 2015;117:157-165. doi: 10.1161/CIRCRESAHA.117.305784.
70. Liang H, Yan X, Pan Y, Wang Y, Wang N, Li L, Liu Y, Chen X, Zhang CY, Gu H, Zen K. MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3. Mol Cancer. 2015;14:58. doi: 10.1186/s12943-015-0327-z.
71. Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and plateletlike particles mediate intercellular RNA transfer. Blood. 2012;119:6288-6295. doi: 10.1182/blood-2011-12-396440.
72. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810-817. doi: 10.1161/CIRCRESAHA.110.226357.
73. Randriamboavonjy V, Isaak J, Elgheznawy A, Pistrosch F, Frömel T, Yin X, Badenhoop K, Heide H, Mayr M, Fleming I. Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood. 2012;120:415-423. doi: 10.1182/blood-2011-12-399980.
74. Zampetaki A, Mayr M. Sweet dicer: impairment of micro-RNA processing by diabetes. Circ Res. 2015;117:116-118. doi: 10.1161/CIRCRESAHA.117.306817.
75. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60:290-299. doi: 10.1016/j.jacc.2012.03.056.
76. Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau DM, Hartmann T, Lackner KJ, Westermann D, Schnabel RB, Blankenberg S, Zeller T. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One. 2015;10:e0145930. doi: 10.1371/journal.pone.0145930.
77. Zampetaki A, Willeit P, Burr S, Yin X, Langley SR, Kiechl S, Klein R, Rossing P, Chaturvedi N, Mayr M. Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes. Diabetes. 2016;65:216-227. doi: 10.2337/db15-0389.
78. Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q, Whiteheart SW, Shaw C, Bray PF. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost. 2010;8:369-378. doi: 10.1111/j.1538-7836.2009.03700.x.
79. Shi R, Ge L, Zhou X, Ji WJ, Lu RY, Zhang YY, Zeng S, Liu X, Zhao JH, Zhang WC, Jiang TM, Li YM. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res. 2013;131:508-513. doi: 10.1016/j.thromres.2013.02.015.
80. Edelstein LC, Simon LM, Montoya RT, Holinstat M, Chen ES, Bergeron A, Kong X, Nagalla S, Mohandas N, Cohen DE, Dong JF, Shaw C, Bray PF. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med. 2013;19:1609-1616. doi: 10.1038/nm.3385.
81. Plé H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P. Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost. 2012;108:605-615. doi: 10.1160/TH12-03-0153.
82. Chyrchel B, Toto-uraska J, Kruszelnicka O, Chyrchel M, Mielecki W, Koton-Wró M, Wokow P, Surdacki A. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Platelets. 2015;26:593-597. doi: 10.3109/09537104.2014.974527.
83. Zhang YY, Zhou X, Ji WJ, Shi R, Lu RY, Li JL, Yang GH, Luo T, Zhang JQ, Zhao JH, Jiang TM, Li YM. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J Thromb Thrombolysis. 2014;38:65-72. doi: 10.1007/s11239-013-1022-9.
84. Leierseder S, Petzold T, Zhang L, Loyer X, Massberg S, Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost. 2013;110:1207-1214. doi: 10.1160/TH13-07-0623.
85. Badrnya S, Baumgartner R, Assinger A. Smoking alters circulating plasma microvesicle pattern and microRNA signatures. Thromb Haemost. 2014;112:128-136. doi: 10.1160/TH13-11-0977.
86. Duan X, Zhan Q, Song B, Zeng S, Zhou J, Long Y, Lu J, Li Z, Yuan M, Chen X, Yang Q, Xia J. Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complications. 2014;28:705-710. doi: 10.1016/j.jdiacomp.2014.04.012.
87. de Boer HC, van Solingen C, Prins J, Duijs JM, Huisman MV, Rabelink TJ, van Zonneveld AJ. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J. 2013;34:3451-3457. doi: 10.1093/eurheartj/eht007.
88. Yu XY, Chen JY, Zheng ZW, Wu H, Li LW, Zhang ZW, Chen ZH, Lin QX, Han YL, Zhong SL. Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. EuroIntervention. 2013;9:546-554. doi: 10.4244/EIJV9I5A90.
89. Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, Wang S, Kiessling F, Olson EN, Weber C. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20:368-376. doi: 10.1038/nm.3487.
90. Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS, Sinning JM, Vasa-Nicotera M, Nickenig G, Werner N. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014;3:e001249. doi: 10.1161/JAHA.114.001249.
91. Pan Y, Liang H, Liu H, Li D, Chen X, Li L, Zhang CY, Zen K. Plateletsecreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol. 2014;192:437-446. doi: 10.4049/jimmunol.1301790.
92. Prokopi M, Mayr M. Proteomics: a reality-check for putative stem cells. Circ Res. 2011;108:499-511. doi: 10.1161/CIRCRESAHA.110.226902.
93. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, Boulanger CM, Westwood N, Urbich C, Willeit J, Steiner M, Breuss J, Xu Q, Kiechl S, Mayr M. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009;114:723-732. doi: 10.1182/blood-2009-02-205930.
94. Köberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bönig H, Peveling-Oberhag J, Biondi RM, Zeuzem S, Kronenberger B, Waidmann O, Piiper A. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One. 2013;8:e75184. doi: 10.1371/journal.pone.0075184.
95. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, Goodman MT, Tait JF, Tewari M, Pritchard CC. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013;8:e64795. doi: 10.1371/journal.pone.0064795.
96. Mitchell AJ, Gray WD, Hayek SS, Ko YA, Thomas S, Rooney K, Awad M, Roback JD, Quyyumi A, Searles CD. Platelets confound the measurement of extracellular miRNA in archived plasma. Sci Rep. 2016;6:32651. doi: 10.1038/srep32651.
97. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5:492-497. doi: 10.1158/1940-6207.CAPR-11-0370.
98. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, Dahlsveen IK. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1-S6. doi: 10.1016/j.ymeth.2012.09.015.
99. Kirschner MB, van Zandwijk N, Reid G. Cell-free microRNAs: potential biomarkers in need of standardized reporting. Front Genet. 2013;4:56. doi: 10.3389/fgene.2013.00056.
100. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, West C, Ragoussis J, Harris AL. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer. 2011;104:1168-1177. doi: 10.1038/sj.bjc.6606076.
101. Benz F, Roderburg C, Vargas Cardenas D, Vucur M, Gautheron J, Koch A, Zimmermann H, Janssen J, Nieuwenhuijsen L, Luedde M, Frey N, Tacke F, Trautwein C, Luedde T. U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med. 2013;45:e42. doi: 10.1038/emm.2013.81.
102. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009;10:R64. doi: 10.1186/gb-2009-10-6-r64.
103. Boeckel JN, Thomé CE, Leistner D, Zeiher AM, Fichtlscherer S, Dimmeler S. Heparin selectively affects the quantification of microRNAs in human blood samples. Clin Chem. 2013;59:1125-1127. doi: 10.1373/clinchem.2012.199505.
104. Kaudewitz D, Lee R, Willeit P, McGregor R, Markus HS, Kiechl S, Zampetaki A, Storey RF, Channon KM, Mayr M. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost. 2013;110:609-615. doi: 10.1160/TH13-05-0368.
105. Freedman JE, Ercan B, Morin KM, Liu CT, Tamer L, Ayaz L, Kanadasi M, Cicek D, Seyhan AI, Akilli RE, Camci C, Cengiz B, Oztuzcu S, Tanriverdi K. The distribution of circulating microRNA and their relation to coronary disease. F1000Res. 2012;1:50. doi: 10.12688/f1000research.1-50.v1.
106. Willeit P, Skroblin P, Kiechl S, Fernández-Hernando C, Mayr M. Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? Eur Heart J. 2016;37:3260-3266. doi: 10.1093/eurheartj/ehw146.
107. Willeit P, Skroblin P, Moschen AR, et al. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type-2-diabetes [published online ahead of print November 29, 2016]. Diabetes. doi: 10.2337/db16-0731. http://diabetes.diabetesjournals.org/content/early/2016/11/22/db16-0731.long.
108. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011;124:1936-1944. doi: 10.1161/CIRCULATIONAHA.111.037572.
109. Varenhorst C, James S, Erlinge D, Brandt JT, Braun OO, Man M, Siegbahn A, Walker J, Wallentin L, Winters KJ, Close SL. Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease. Eur Heart J. 2009;30:1744-1752. doi: 10.1093/eurheartj/ehp157.
110. Osman A, Fälker K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets. 2011;22:433-441. doi: 10.3109/09537104.2011.560305.